Discovery and preclinical characterization of dual antagonist antibodies targeting both LILRB1 and LILRB2 that enhance innate and adaptive anti-cancer immune responsesCANCER RESEARCHIF16.62023-04-040PRE
Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine NeuroblastomaFRONTIERS IN IMMUNOLOGYIF5.92021-08-197OAAI
Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservationCYTOTHERAPYIF3.22020-08-0121OAAI
Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell BindingMOLECULAR CANCER THERAPEUTICSIF5.52020-03-0266OAAI
AO-176, a highly differentiated humanized anti-CD47 antibody, exhibits single -agent and combination antitumor efficacy with chemotherapy and targeted antibodiesMOLECULAR CANCER THERAPEUTICSIF5.52019-12-011PRE
A humanized anti-CD47 monoclonal antibody that directly kills human tumor cells and has additional unique functional characteristicsCANCER RESEARCHIF16.62018-07-012PRE
An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer CellsFRONTIERS IN IMMUNOLOGYIF5.92018-02-0228OAAI
FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphomaONCOGENEIF7.32016-05-0959OAAI
Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent ImmunityIMMUNITYIF26.32015-08-0198OAAI
Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged miceJOURNAL OF EXPERIMENTAL MEDICINEIF10.62014-11-03119OAAI
Impact of aging in cancer immunotherapy The importance of using accurate preclinical modelsONCOIMMUNOLOGYIF6.32014-10-2724OAAI
Increased Antitumor Effects Using IL-2 with Anti-TGF-β Reveals Competition between Mouse NK and CD8 T CellsJOURNAL OF IMMUNOLOGYIF3.42014-08-1542OAAI
Quantifying 19F-Labeled Human Natural Killer Cell-Trafficking with MRIMEDICAL PHYSICSIF3.22014-05-290PRE
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy肿瘤免疫治疗后衰老易发生急性炎症诱导病理JOURNAL OF EXPERIMENTAL MEDICINEIF10.62013-09-30136OAAI
Monitoring of 19F-Labeled Immune Cell Trafficking During Radiotherapy Using MRIMEDICAL PHYSICSIF3.22013-06-060PRE
IFN-γ Receptor-Deficient Donor T Cells Mediate Protection from Graft-versus-Host Disease and Preserve Graft-versus-Tumor Responses after Allogeneic Bone Marrow TransplantationJOURNAL OF IMMUNOLOGYIF3.42012-08-1519OAAI